Dr. DaRe is board-certified in Clinical Molecular Genetics by the American Board of Medical Genetics and Genomics and joined Labcorp Genetics, formerly known as Invitae in 2021. Prior to joining Invitae/Labcorp Genetics, Dr. DaRe was the Vice President of Laboratory Medicine at Progenity, where she was responsible for leading the Laboratory Director team, overseeing the Medical Affairs team, and bringing clinical molecular genetics expertise to Progenity’s new product development and commercialization pipeline.
Before that, Dr. DaRe was the Laboratory Director at Transgenomic, where she helped bring one of the first large next-generation sequencing panels for the diagnosis of rare disease to the clinical laboratory industry. Dr. DaRe completed her clinical training in 2011 through a joint program located at Providence Sacred Heart Medical Center and Signature Genomics Laboratories in Spokane, WA. She earned her doctoral degree in Genetics in 2009 from Case Western Reserve University, in Cleveland, OH.
Areas of Support: Molecular Genetics and Genomics
Memberships: Fellow of the American College of Medical Genetics and Genomics
Board Certifications: Clinical Molecular Genetics by the American Board of Medical Genetics and Genomics
Publications:
- Owens KM, Dohany L, Holland C, DaRe J, Mann T, Settler C, Longman RE. 2018. “FMR1 premutation frequency in a large, ethnically diverse population referred for carrier testing.” Am J Med Genet A. Jun;176(6):1304-1308
- Falk MJ, Shen L, Gonzalez M, Leipzig J, Lott MT, Stassen AP, Diroma MA, Navarro-Gomez D, Yeske P, Bai R, Boles RG, Brilhante V, Ralph D, DaRe JT, Shelton R, Terry SF, Zhang Z, Copeland WC, van Oven M, Prokisch H, Wallace DC, Attimonelli M, Krotoski D, Zuchner S, Gai X. 2014. “Mitochondrial Disease Sequence Data Resource (MSeqDR): A global grass-roots consortium to facilitate deposition, curation, annotation, and integrated analysis of genomic data for the mitochondrial disease clinical and research communities.” Molecular Genetics and Metabolism. Vol. 114 No. 3 pg. 388-96.
- DaRe JT, Vasta V, Penn J, Tran T, Hahn S. 2013. “Targeted exome sequencing for mitochondrial disorders reveals high genetic heterogeneity.” BMC Medical Genetics. Vol 14 No.118.